Biotech

All Articles

Repare gives up 25% of team as biotech stops preclinical R&ampD

.Repare Therapeutics is laying off an one-fourth of its own labor force as the oncology biotech less...

J &amp J declare FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten yet another measure toward realizing a return on its own $...

Gain's stage 1 succeed leads way to prove Parkinson's medication's worth

.Gain Rehabs has established its own direct verifying the performance of its own Parkinson's conditi...

Actinogen reports brand-new phase 2 records to save depression drug

.Actinogen Medical's chances-- and also supply price-- have actually rebounded a little from previou...

Pfizer and also Main incorporate Quotient to multibillion-dollar equation

.Crown Jewel Pioneering and also Pfizer have actually added Quotient into their 10-program collabora...

Bayer pens $547M contract to drive borders of noncoding RNA

.Bayer execs were actually interested to stress to Ferocious this summer season that the German phar...

UK unveils plans to introduce 18 new professional test hubs

.Amid a yearslong scientific trial decline in the U.K., a brand-new public-private relationship has ...

UPDATE: Genentech telegraphs 93 discharges in The golden state after discussing plannings to shutter cancer cells immunology research unit

.Adhering to the statement of a big cutback shot in April and a major restructuring effort unveiled ...

Neurocrine's KarXT rival hits in stage 2-- yet only at low dose

.Neurocrine Biosciences has achieved its hoped-for account in a phase 2 mental illness test, supplyi...

Vaderis' unusual blood vessel problem medication minimizes nosebleeds

.Vaderis Therapeutics' goal to build the very first medicine aimed primarily at a certain unusual ca...